Interleukin-2 receptor activation by an anti-IL-2Rβ/γc bispecific antibody
Interleukin-2 (IL-2) is an immunostimulatory cytokine that acts as a mitogen for T cells and natural killer (NK) cells. There is an increasing interest in using IL-2 as a therapeutic agent to combat cancers and infectious pathogens. However, it has not been successfully utilized in a clinical sett...
Main Author: | Brauer, Peter |
---|---|
Other Authors: | - |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/66329 |
Similar Items
-
TCB2, a new anti-human interleukin-2 antibody, facilitates heterodimeric IL-2 receptor signaling and improves anti-tumor immunity
by: Jun-Young Lee, et al.
Published: (2020-01-01) -
Interleukin-2 (IL-2) Interacts With IL-2 Receptor Beta (IL-2Rβ): Its Potential to Enhance the Proliferation of CD4+ T Lymphocytes in Flounder (Paralichthys olivaceus)
by: Xiujuan Zhou, et al.
Published: (2020-09-01) -
A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells
by: Katherine E. Harris, et al.
Published: (2021-05-01) -
Bispecific Antibodies for IFN-β Delivery to ErbB2<sup>+</sup> Tumors
by: Vladislav S. Rybchenko, et al.
Published: (2021-12-01) -
Vγ2 x PD-L1, a Bispecific Antibody Targeting Both the Vγ2 TCR and PD-L1, Improves the Anti-Tumor Response of Vγ2Vδ2 T Cell
by: Rui Yang, et al.
Published: (2022-06-01)